A systematic review of biomarkers for disease progression in Parkinson’s disease

BACKGROUND: Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true disease-modifying effects. A systematic review was undertaken to determine what biomarkers for disea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McGhee, David JM, Royle, Pamela L, Thompson, Paul A, Wright, David E, Zajicek, John P, Counsell, Carl E
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637496/
https://ncbi.nlm.nih.gov/pubmed/23587062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-13-35
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados